PDC*line Pharma presents first clinical results from Phase I/II trial with PDC*lung01 at ESMO 2022

Preliminary results with PDC*lung01 in monotherapy and at low dose with pembrolizumab evoke...

Press releases

We are thrilled to announce that PDC*line Pharma will be presenting a poster at the ESMO - European Society for Medical Oncology Annual Meeting 2022 taking place from 9 to 13 September 2022, in Paris,...

Events

PDC*line Pharma is hiring a Quality Assurance and Logistics Assistant in Belgium. Are you interested to join an international dynamic team in the biotech cancer vaccine space? Be part of the adventure...

Jobs

PDC*line Pharma is #hiring a Quality Control Technician in Belgium. Are you interested to join an international dynamic team in the biotech cancer vaccine space? Be part of the adventure and join us!

...
Jobs

PDC*line Pharma is hiring a Senior Production Supervisor / Production Technician in Belgium. Are you interested to join an international dynamic team in the biotech cancer vaccine space?

Be part of...

Jobs

Very are delighted to announce that our CEO Eric Halioua will chair a panel April 28th at the 5th Neoantigen Summit Europe organized by Hanso Wade in Amsterdam, Netherlands from April 26th to April...

Events

We are delighted to announce of the publication by our CSO Joël Plumas of a new review article in scientific journal Current Opinion in Oncology and intitled "Harnessing dendritic cells for innovative...

In the press

PDC*line Pharma raises €17.5 million ($20,3M) in Series B2 financing round

New funding includes €11.8M in equity and €5.7M in grants. It completes the €20M B1 round of financing announced in January...

Press releases

B2 cohort (high dose added to anti-PD-1) of the PDC-LUNG-101 trial with PDC*lung01 therapeutic cancer vaccine candidate for non-small cell lung cancer has been opened and first patients were dosed

 ...

Press releases